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Abstract
Background: The Monte Carlo code GEANT4 was used to implement first steps towards a treatment planning
program for fast-neutron therapy at the FRM II research reactor in Garching, Germany. Depth dose curves were
calculated inside a water phantom using measured primary neutron and simulated primary photon spectra and
compared with depth dose curves measured earlier. The calculations were performed with GEANT4 in two
different ways, simulating a simple box geometry and splitting this box into millions of small voxels (this was done
to validate the voxelisation procedure that was also used to voxelise the human body).
Results: In both cases, the dose distributions were very similar to those measured in the water phantom, up to a
depth of 30 cm. In order to model the situation of patients treated at the FRM II MEDAPP therapy beamline for
salivary gland tumors, a human voxel phantom was implemented in GEANT4 and irradiated with the implemented
MEDAPP neutron and photon spectra. The 3D dose distribution calculated inside the head of the phantom was
similar to the depth dose curves in the water phantom, with some differences that are explained by differences in
elementary composition. The lateral dose distribution was studied at various depths. The calculated cumulative
dose volume histograms for the voxel phantom show the exposure of organs at risk surrounding the tumor.
Conclusions: In order to minimize the dose to healthy tissue, a conformal treatment is necessary. This can only be
accomplished with the help of an advanced treatment planning system like the one developed here. Although all
calculations were done for absorbed dose only, any biological dose weighting can be implemented easily, to take
into account the increased radiobiological effectiveness of neutrons compared to photons.
Background
At the former research reactor FRM at Garching, Ger-
many, neutrons have been used for radiation therapy since
1985, and 715 patients with different types of tumors were
treated until its shut-down in July 2000. Since June 2007,
neutron irradiation treatments are performed at the new
Medical Application facility (MEDAPP) at the Research
Neutron Source Heinz Maier-Leibnitz (FRM II) [1,2]. This
new reactor was designed to provide a very high neutron
fluence rate, primarily at thermal energies. In the modera-
tor tank of the reactor, the low-energy neutrons are con-
verted by two uranium plates to high-energy neutrons for
medical (and other) applications at beamline SR 10. Filters
are used to match the beam characteristics (i.e., neutron
spectrum and the neutron-to-photon ratio) to those of the
first facility at the former FRM. For this reason, medical
knowledge acquired during the operation of the first reac-
tor can be used for the treatment at the FRM II. As main
improvements to the earlier facility, the new facility
includes a 3-fold increase in total neutron fluence rate and
up to a 6-fold increase in field size [3]. This leads to a
decrease in treatment time and to an improvement of
treatment conditions and quality, which are now compar-
able to those at other neutron therapy facilities like for
example at Seattle, Fermilab or iThemba [4-6].
The next step of improvement would be to introduce a
computer-based treatment planning system rather than to
use waterphantom depth-dose curves for dose estimation
which are used at the moment in a certificated (CE) proce-
dure. The physical basics for such a planning system have
already been thoroughly explored both by using the
Monte Carlo Code GEANT4 for simulations of neutron
and photon transport [7,8], and by using a Bonner sphere
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at the patient position.
It is noted that in the past, different Monte Carlo algo-
rithms have been applied for dose assessment in radiation
therapy. For example, several different programs (includ-
ing MCNP, MCNPX, EGS4, BEAMnrc VMC, PHITS,
GEANT4) were used to simulate photons and electrons
[10-16], protons [17-21], neutrons [22,23] and dose from
secondary neutrons during proton and
12Ci r r a d i a t i o n
[24-27]. GEANT4 also offers the opportunity to calculate
the 3D dose distribution of various particles including
neutrons, photons and all secondary particles [28]. In addi-
tion it allows to include any weighting function for calcu-
lation of biologically-weighted doses. This was shown e.g.
by [29] to be important for future dose assessment of high
LET-irradiation.
This work presents the results of a detailed simulation of
water phantom depth-dose curves with GEANT4, based
on the measured neutron energy spectrum at the patient
treatment position, and its comparison with measure-
ments [30]. First steps towards a patient dose calculation
were performed inside a voxel phantom [31] recom-
mended by the International Commission on Radiation
Protection (ICRP) for use in radiation protection (ICRP
103/Match 2007). It is shown that the implemented pro-
gram allows calculation of 3D-distributions of neutron
and photon absorbed dose.
Material and methods
The Monte Carlo code GEANT4
GEANT4 version 4.8.2 ran on a SuSe-linux system. The
neutron-data library G4NDL 3.10 was installed which is
based on the ENDF/B-VI cross section evaluation [32].
The required GEANT4-physics list was built including
low energy processes. In particular, the S(a, b)-matrix was
implemented to simulate thermal elastic scattering. A
detailed description and testing of this physics list is given
in [7,33]. The importance of the S(a, b)-reaction was also
discussed by Enger et al [22].
The deposited energy was calculated with a scorer
(G4DoseDeposit), which was modified to determine
also the statistical error of the dose. The G4SDParti-
cleFilter was applied to score the absorbed dose
deposited by photons, electrons, protons and neutrons
separately. In order to calculate the neutron fluence rate,
an energy-binned G4CellFlux scorer was used, which
was also modified to calculate the statistical error. The
binning was done with G4SDParticleWithEnergy-
Filter. Details on the usage of GEANT4 can be found
in [34].
Geometry of the water phantom
In earlier measurements [1,30] the neutron and photon
depth-dose curves in a water phantom were determined
by a pair of thimble chambers with different neutron
sensitivity that were irradiated at the patient position
(EXTRADIN-chamber one out of tissue-equivalent (TE)
material A150 with TE gas; sensitivity to neutrons/
gamma = 48.5/51.5%; chamber two out of Mg/Ar, neu-
tron sensitivity 2%, chamber volume: 0.5 cm
3). The
phantom consisted of a box of Perspex filled with about
1701 of water with an entrance window for the horizon-
tal beam and a device to position the ionization cham-
bers. This water phantom was simulated here in two
different ways (see Figure 1): as a solid box with small
measurement chambers inside and in voxelised form
consisting of over 10 millions of box-shaped volume ele-
ments ("voxels”). Both phantoms consisted of water and
were put into a cubic container made of Perspex with
dimensions 63.5 × 63.5 × 52 cm
3 and 2.0 cm wall thick-
ness (like in the real experiment, material definition see
Table1). For the voxelised phantom, the dimensions
were slightly enlarged to 64 × 64 × 52 cm
3 to simplify the
voxelisation algorithm, and voxel sizes of 0.2 × 0.2 ×
0.5 cm
3 were used in accordance with those used typically
in CT-imaging for radiation therapy. The Perspex con-
tainer also included the entrance window of 12 × 34 cm
2
size sealed with two aluminum plates of 1.5 mm thickness.
The volume inside the solid water box, where the mea-
surements were performed, was simulated as an array of
tube-shaped chambers with a radius of 0.38 cm, a height
of 1.21 cm and a volume of 0.54 cm
3 that also consisted of
water, in order to simulate an undisturbed measurement.
Note that after the measurement, the doses measured
inside the water phantom by means of the ionization
chambers were corrected for the influence of the chamber
on the measurement to provide the doses in an undis-
turbed phantom [3,30]. In the simulation, the chambers
were parameterized in such a way that the first chamber
was placed at 0.5 cm depth in water, followed every centi-
meter by another detector chamber. This array of tube-
shaped chambers corresponds well with the ionization
chamber used for the real measurements (volume 0.5 cm
3
[3]). In total there were 40 measurement volumes, which
corresponds to a maximum depth of 39.5 cm. In the case
of the voxelised phantom, the parameterized chambers
were removed and the depth-dose scoring was done
directly inside the voxels.
In the voxelised geometry, the total absorbed dose and
the absorbed dose from primary and secondary photons
and electrons were scored separately, simulating the real
measurement, where both the neutron and photon doses
were determined. In the case of the solid box geometry it
was possible to collect more information, because less
scoring volumes were present and therefore less data sto-
rage space was needed for each quantity. The total, neu-
tron, proton, electron/positron and photon dose were all
scored separately as well as the local moderated neutron
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lation time for the solid box is about 3.5 times faster (4h
compared to 14h for 10
6 primary neutrons on a 3.2 GHz
processor pc).
For the solid box geometry, the influence of the sur-
rounding walls, floor and roof of the therapy room was
also studied. For this, the patient treatment room was
implemented in a schematic way, using G4-concrete
from the NIST-material database as wall material [35].
T h ew a l l sw e r es i m u l a t e dt ob e8 3c mt h i c k( 5 0c mi n
case of the beam exit wall) with a beam exit window of
20 × 30 cm
2. In Figure 2, the top-view of the MEDAPP
therapy room as simulated in GEANT4 is shown
together with 10 neutron tracks using a neutron spec-
trum that had been measured by means of a Bonner
sphere spectrometer at the patient position [9,33].
In both geometries, the primary neutron and photon
beam cross section was a square of 9 × 9 cm
2,w h i c hi s
the same as the one used for the measurements [1,3].
Geometry of the human voxel phantom
The human voxel phantom used here is based on CT-
scans of a real person. The Hounsfield numbers of the
CT-slices were translated to 141 organ-IDs by hand,
using anatomical atlases [31]. Each voxel has the size
1.775 × 1.775 × 4.84 mm
3 ( x ,y ,z - d i r e c t i o n ) ,w i t ht h e
long side of the voxel aligned along the z-axis of the
voxel phantom (increasing from toe to head). In total,
there are 299 columns, 137 rows and 337 slices (x, y, z-
direction) of voxels in the phantom, with vacuum-filled
voxels surrounding the human body. The phantom
represents an idealized female of 163 cm height and 60
Figure 1 Geometry of the Water Phantom. The two geometry types used for the simulation of the water phantom: left: solid box phantom
with the measurement chambers inside (which are also out of water; 30 of the 40 chambers used in the calculations are shown) with one
incoming neutron track; right: x-y-plane of the voxelised water phantom with tracks from 100 primary neutrons of the FRM II beam. For
visualization purposes, a 2 cm voxel size was used here, instead of the 2 mm used in the actual GEANT4 simulations.
Table 1 Specification of Perspex in GEANT4
atomic composition * physical quantities
ratio of elements: temperature = 300 K
C: 5 state of aggregation = solid (kStateSolid)
O: 2 density = 1.19 g/cm
3
H: 8 for energy loss purposes:
ChemicalFormula = “(C_2H_4)_N_Polyethylene”
hydrogen in water (TS_H_of_Water) was used for the thermal scattering of
neutrons; *natural composition of isotopes
Figure 2 Geometry of the MEDAPP Room at the FRM II.W a l l
material: G4-concrete; max. beam window: 20 × 30 cm
2; distance to
floor/ceiling: 145 cm; thin lines: 10 neutron tracks; thick gray line:
neutron therapy beam.
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from the CT-scan of a woman (Laura: 167 cm height, 59
kg). Compared to the original phantom Laura, the voxel
size was changed, and the masses of individual organs
were adjusted to reference values, to fulfill the require-
ments of ICRP 89 [36], using anatomical books for gui-
dance. In this way, the Reference Female REGINA that
was used in the present task was constructed.
Because the application of the FRM II neutron beam is
most promising for the head and neck region, only the
upper quarter of the voxel phantom (including 87 slices)
was used for the calculations. The orientation of the voxel
phantom in GEANT4 is the following: the column num-
bers (x-direction) increase from the right to the left side of
the phantom, the row numbers (y-direction) increase from
the nose to the back side of the head, and the slice num-
bers (z-direction) increase from the breast to the head.
The voxel phantom was implemented in GEANT4 using
the fast phantom parameterization (imported from version
4.9.0 into the used version 4.8.2), which includes all voxels
(also the surrounding vacuum voxels) and identifies a spe-
cific voxel by its position in the grid. This algorithm is
very fast but requires a lot of memory because the scored
information is saved for all voxels that are placed.
T h em a t e r i a lo ft h ev o x e la t( x ,y ,z ) - p o s i t i o ni ss e t
according to the number given in the phantom’sd a t a -
file: the 141 organ IDs are projected onto 30 different
materials (with arbitrary numbers) which are then used
in the calculations (see [31] for details on the atomic
composition and organ-to-material conversion).
The chosen test case was a salivary gland treatment of
the right submandibular gland (lower jaw salivary gland).
Because the real field size applied to the patient was almost
a rectangle (see left side of Figure 3, a rectangular beam
with 6 cm × 7 cm cross section was used in the simulations
hitting the patient from the right side with a beam direc-
tion along the positive x-axis. In contrast to the real
situation, the beam profile was also simulated to be rectan-
gular (see next section ). The position of the beam was
simulated in resemblance to that of the real patient case
using the skeletal structure as a guideline. It should be
emphasized, however, that some approximations had to be
made because the head-to-body angle of the voxel phan-
tom was somewhat different to that of the real case (see
Figure 3). In this way, the calculation algorithm could be
tested and a first assessment of the absorbed dose distribu-
tion was possible. It should be noted that the field shape
can easily be changed in the simulation to adapt it to the
shape of the planning target volume (PTV) if necessary.
Primary neutron and photon spectrum
The absorbed dose rate (in Gy/s) was determined in
GEANT4 by multiplication of the calculated absorbed
dose deposited inside the chamber or voxel per primary
neutron or photon fluence (resulting in a value with the
unit Gycm
2) with a total primary neutron fluence rate of
3.2 · 10
8 cm
-2s
-1 and a total primary photon fluence rate of
2.9 · 10
8 cm
-2s
-1. The primary neutron fluence rate had
independently been determined before by gold-foil activa-
tion measurements in a water phantom [37] and by Bon-
ner sphere measurements rescaled to the patient
treatment position in the MEDAPP therapy room [9],
while the primary photon fluence rate was derived from
the comparison of calculated and measured depth-dose
curves in water (see discussion below). To get the absolute
absorbed dose for a specific treatment field inside the
voxel phantom, the resulting values were finally multiplied
by the actual irradiation time. In Figure 4, the neutron
(measured by a BSS spectrometer [9]) and photon (calcu-
lated with MCNP [38]) primary spectra are normalized to
Figure 3 Beam Position and Size. Comparison of beam position
and size for a real patient treatment (left panel; Loeper, MRI/TUM,
priv. com.) and the simulated field in the human voxel phantom
(gray lines in right panel).
Figure 4 Neutron and Photon Spectrum. Neutron and photon
spectrum with total particle fluence rate of 3.2 · 10
8 cm
-2s
-1 and 2.9
·1 0
8 cm
-2s
-1, respectively; neutron spectrum measured with BSS [9];
photon spectrum calculated with MCNP by [38].
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8 cm
-2s
-1 for neutrons and
2.9 · 10
8 cm
-2s
-1 for photons, respectively.
In order to sample the neutrons and photons in the cal-
culation according to the measured/calculated spectra,
these spectra were integrated and normalized. From the
resulting probability function, the primary neutrons and
photons were sampled using random numbers.
The primary neutrons and photons were simulated to be
homogeneously distributed over the whole beam. Further-
more, the beam profile was approximated to be rectangu-
lar with no decrease towards the edges. This is a
simplification as the real beam is spread because of neu-
tron scattering inside the beam tube and the large lateral
dimensions of the source. Therefore, the real beam has a
shallow decline towards the edges [37].
Results and Discussion
Calculated depth-dose curves in the water phantom
Neutrons
In Figure 5, the calculated absorbed dose rates in the
solid-box and the voxelised geometry are shown
together with the measured depth dose curve. The
results of the solid box and the voxelised geometry are
in excellent agreement. The latter were integrated over
4 voxels in lateral and 2 voxels in vertical direction
around the central beam axis, resulting in a dose collec-
tion volume of 0.16 cm
3 from 8 voxels, to get better
statistics. Figure 5 demonstrates that the voxelisation
algorithm produces the same results as the solid-box
calculation.
Figure 5 also demonstrates the excellent agreement of
the calculations with the measurements. For example,
the decrease of the dose rate with depth is very similar
for both cases. Small differences between the measured
and the calculated curves in terms of their absolute
values could be - among other reasons - due to the dif-
ferent date of the measurement (the Bonner sphere
measurements were performed approximately 1 year
after the depth dose measurements, resulting in a small
converter plate burn-up of approximately 2% [37]) and,
for greater depths, due to calculation statistics. Further-
more, changes in the humidity of the air in the treat-
ment room and the beam tube as well as the exact
position of the control rods have an influence on the
neutron spectrum and therefore can also change the
deposited dose.
Finally, the comparison between the depth dose curves
calculated with and without the concrete walls of the
treatment room (Figure 5) demonstrate the influence of
these walls to be of minor importance. For example, for
small and medium depths (up to 10 cm) it is less than
2%. Thus, it is not necessary to consider the treatment
room when calculating the dose inside the beam in the
voxel phantom.
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Figure 5 Neutron Dose Rate. Neutron dose rate in the water phantom (beam profile of 9 × 9 cm
2 ): comparison of the voxelised (green
triangle, integration over 8 central voxels) and the solid box geometry (blue circle = with walls, pink circle = without walls) calculated
with GEANT4 (error bars provide one standard deviation as calculated in GEANT4), together with the measurement of Kampfer [30] (red
square).
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The primary FRM II treatment beam also includes a
photon component, which is caused by prompt gammas
during fission, by delayed gammas from fission products
in the converter plate, by gammas from activated struc-
tures and by Compton scattered gammas from the reac-
tor core. This primary photon spectrum is not yet
characterized experimentally. However, an MCNP calcu-
lation has already been performed [38], transporting the
photons through the beam tube up to the patient treat-
ment position. With this program, it was not possible to
simulate exactly the production of photons from the
decay of activation and delayed fission products in the
converter plates: The simulation resulted in an overall
photon fluence rate which was 40% too low, and in a
poor reliability of the photon spectrum. Nevertheless,
this spectrum was used as a first estimate, to obtain
information on the photon depth dose distribution inside
the phantom.
For the calculations inside the water phantom, both the
solid box and voxelised geometry were used (with and
without surrounding walls), and the results compared to
the measured data [1]. It should be noted that the mea-
sured photon dose rate also includes contributions from
secondary photons produced by the neutrons inside the
water phantom, as the twin method applied in the mea-
surements does not distinguish between primary and
secondary photons.
As for the neutron calculations, the photon calculations
in the voxelised and solid-box geometry produce very
similar results. Furthermore and similar to the neutron
case, inclusion of the surrounding walls does not influ-
ence the calculated dose rates. In Figure 6, both the dose
rate from primary and secondary photons which were
produced by interaction of primary neutrons with the
phantom material, are shown. Because the depth-dose
curve of the neutrons is consistent with the measured
data both in relative and absolute terms (see previous
Figure 6 Primary and Secondary Photon Dose Rate. Primary and secondary photon dose rate calculated in the solid-box water phantom
(error bars provide one standard deviation as calculated in GEANT4), in comparison to measured [30] data (beam profile of 9 × 9 cm
2); □ = total
dose rate from primary (Δ) and secondary (○) photons; ■ = total dose rate from the re-normalized dose rate of primary photons together with
that of the secondary photons. Note that while the absolute uncertainties seem to decrease with depth, the relative uncertainties increase with
depth.
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produced by neutrons is also correct on an absolute
scale. On average, the contribution from the secondary
photons amounts to about 10-15% of the total measured
photon dose rate in the first centimeters. The total pri-
mary photon fluence rate used in the simulations (i.e., 1.8
·1 0
8 cm
-2s
-1, calculated by integrating the photon spec-
trum) is not correct on an absolute scale (see discussion
above) but had to be increased until the sum of the calcu-
lated depth dose curves of the primary and secondary
photons matched the measurements in the first 10 cm,
and a best estimate of the primary photon fluence rate of
2.9 · 10
8 cm
-2s
-1 was obtained which agrees well with the
expected total photon fluence rate (see above). This
means that the incident primary total fluence rates of
photons and neutrons are rather similar. Though the pri-
mary photon spectra is expected to be softer, the shapes
of the depth dose curves do not deviate much in the first
10 cm (see Figure 6). Therefore, it is concluded that the
primary photon spectrum derived here can be used
together with the renormalized total fluence rate for first
calculations in the voxel phantom.
Calculated doses in the voxel phantom REGINA
Depth-dose curves and lateral distribution
In Figure 7, the calculated depth-dose curve along the cen-
tral beam is compared to that obtained in the water phan-
tom. The decrease of dose with depth is similar for both
phantoms, but slightly steeper for the voxel phantom,
because its atomic composition is different from water (for
example, the hydrogen content in adipose tissue (material
number 28, see section about the geometry of the voxel
phantom ) is 62.5% compared to 66.7% in water). The
change of material with depth in the REGINA phantom is
also indicated in the figure. When the material changes, e.
g., from 19 (skin) to 28 (adipose tissue) or to 21 (muscle),
the atomic composition changes and therefore a change in
the dose can also be seen. In Figure 8, the lateral absorbed
dose distribution is shown for three different columns
inside the REGINA voxel phantom: x = 130, 150 and 170,
Figure 7 Absorbed Depth-Dose Curves. Absorbed depth-dose curves for the FRM II neutron beam in the REGINA phantom, at slice number
45 and row number 48 (beam center; ■), assuming a rectangular beam profile of 6 × 7 cm
2, and in the voxelised water phantom (○); All curves
were calculated for 3 min irradiation with a primary neutron fluence rate of 3.2 · 10
8n/cm
2s (no primary photons); for comparison, material
numbers in the REGINA phantom along the central beam are included on the right y-axis (19: skin, 21: muscle, 28: adipose tissue).
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neutrons are significantly scattered inside the REGINA
voxel phantom and deposit their energy not only inside
the beam profile but also in the surrounding tissue. This
can be seen at a row (y)-value of 40, where the sharp
edges of the simulated rectangular beam can still be seen
for small depths (x = 130 is equal to 0.3 cm depth at this
y-value) inside the phantom. These sharp edges are
washed out with depth, so that in greater depths (e.g. x =
170 or 7.4 cm), the lateral dose is spread over several cen-
timeters (the relative decrease in absorbed dose between y
= 39 and y = 41 compared to the dose at y = 41 is 93% for
x = 130, 73% for x = 150 and 64% for x = 170). At a y-
v a l u eo fa b o u t7 4 ,t h en e u t r o n sh a v ea l r e a d yp a s s e d
through a certain thickness of tissue (i.e., x = 130 is equal
to 2.0 cm depth at this y-value) and the changes of the lat-
eral spread at the same x-values is less prominent (relative
decrease in absorbed dose between y = 73 and y = 75 is
83%/68%/64% for x = 130/150/170, respectively). Note
that the beam spread is expected to be even more
pronounced for the real beam, because the beam diver-
gence of 1-2° as well as the penumbra of the different fil-
ters and collimators were not included in the calculations,
but would further increase the lateral spread of the beam
(see the discussion in the section about the neutron and
photon spectra). Furthermore, the influence of the mate-
rial is visible in Figure 8 as well. At the same x-value, the
dose declines towards higher y-values, which correspond
to the back side of the phantom. This is caused by the
phantom’s uneven surface. Looking at the relevant slice
(z = 44, see inset), it can be seen that the neck starts to
bulge in the relevant area. Therefore, the radiation is
absorbed before reaching the relevant depth whereas at
lower y-values (40-55), less material is present. For the
green data points (x = 150) an area of high statistical
uncertainty can be seen between y-values of 60 to 66. This
is the area where the trachea is located, where fewer parti-
cles interact with the air inside and deposit dose there.
Behind this area, more energy is therefore deposited which
can indeed be seen in the data of (x = 170). Another
Figure 8 Absorbed Lateral Dose Distribution. Absorbed lateral dose distribution of the 6 × 7 cm
2 FRM II neutron beam in different depths
inside the REGINA voxel phantom after 3 minutes of irradiation with a total primary neutron fiuence rate of 3.2 · 10
8n/cm
2s (no primary
photons) in slice (z) number 44 assuming a rectangular lateral beam profile.
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69, 77 in depth x = 150, where the deposited dose is much
s m a l l e rt h a ni nt h es u r r o u n d ing voxels. The material at
this position is hard bone (cortical), with a hydrogen con-
tent of only 3.5% (fractionmass) compared to more than 8
for all other soft matter (also bone marrow and spongiosa).
Because the neutron dose deposition mainly depends on
the hydrogen content of the present material, the dose in
these voxels is about half of the dose in other voxels.
Dose volume histograms
In patient treatment planning, a tool used for plan quality
assessment is the dose-volume-histogram (DVH). In this
histogram, the detailed spacial data is condensed into a
plot with the fraction of volume of an organ irradiated
with a certain dose on the y-axis and the corresponding
absorbed dose on the x-axis. In the left panel of Figure 9,
the cumulative DVH of the studied salivary gland case is
shown for six organs: the healthy salivary glands of the
REGINA phantom’s left side, the treated right subman-
dibular gland, and the (healthy) right sublingual and par-
otid gland which are also partly in the beam. It should be
emphasized that in a real case, the neutron treatment is
given mostly as a boost after a normal photon treatment
at a linear accelerator. If the doses from the photon treat-
ment were included, the DVH would change signifi-
cantly. Furthermore, only the physical absorbed dose was
considered here without biological weighting of the neu-
tron dose. If such a biological weighting was included,
the DVHs would also change because of the different
fraction of dose deposited by photons, depending on the
organ’s position inside the body.
T h er i g h tp a n e lo fF i g u r e9s h o w st h ed e p e n d e n c eo f
the DVH of the two submandibular glands on the inclu-
sion of the RBE. For this qualitative analysis, a clinical
RBE of three (derived from old clinical data (Wagner,
priv com.)) for the neutrons was included after the
Monte Carlo calculation, to estimate the influence of a
biological weighting for neutrons and their secondary
particles. However, at the current state of investigation a
proper RBE as a function of neutron energy is not avail-
able. The fraction of dose deposited by photons is larger
for the left than for the right submandibular gland.
Therefore, the ratio of the weighted dose compared to
the absorbed dose is larger for the right submandibular
gland than for the left one. This reduces the effective
dose in the healthy submandibular gland and similarly in
other deeper-located organs.
Isodoses
I nt h et o pl e f tp a n e lo fF i g u r e1 0 ,o n es l i c eo ft h ev o x e l
phantom is shown together with the isodose lines of the
irradiation with the FRM II neutron spectrum. The iso-
dose lines were achieved by a spline interpolation of the
calculated dose-matrix. In hard bone material, lower
doses can be observed which may be due to the lower
hydrogen content (31.2% element abundance compared
to 62.5% in adipose tissue). Inside air cavities such as the
trachea, the deposited dose is also somewhat reduced,
due to the low density and the lack of hydrogen. This can
be seen in the middle part of the slice. In the top right
panel of Figure 10, the primary photon absorbed dose
with depth is shown, while the lower panel shows the
total absorbed dose from primary neutrons and photons
(here neutrons are not weighted for their increased biolo-
gical effectiveness compared to that of photons). It can be
seen that the total absorbed dose is about 0.5 Gy higher
with the primary photons than without. This is particu-
larly important for the healthy left salivary gland, because
the depth-dose curve of the photons is very shallow. This
effect leads to an increased absorbed dose to healthy tis-
sues behind the tumor. Introducing the real distribution
of neutrons and photons (including the beam spread)
would not change this conclusion significantly. It should
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Figure 9 Dose-Volume-Histogram. Cumulative (left) dose-volume-histogram (DVH) of the salivary glands after 3 min irradiation with the 6 × 7
cm
2 FRM II neutron beam, a total primary neutron fluence rate of 3.2 · 10
8 n/cm
2s and a total primary photon fluence rate of 2.9 · 10
8 7/cm
2s; r
= right, 1 = left; subman gl = submandibular gland; subli gl = sublingual gland; par gl = parotid gland. Right histogram: dependence of DVH of
right and left submandibular glands on RBE, dose normalized to dose at 50% volume of the right/left submandibular gland respectively.
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Page 9 of 12Figure 10 Absorbed Dose inside REGINA Voxel Phantom. Absorbed dose inside REGINA voxel phantom after 3 min irradiation with the 6 ×
7c m
2 FRM II beam, a total primary neutron fluence rate of 3.2 · 10
8n/cm
2s and a total primary photon fluence rate of 2.9 · 10
8n/cm
2s; all
contour lines relative to the prescribed dose of 2 Gy (in %); slice 45; in red/blue, the right/left salivary glands are highlighted; top left: dose from
primary neutrons; top right: dose from primary photons; bottom: total dose; No biological weighting for the neutrons was applied in the figure.
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Page 10 of 12be noted here that the biological effectiveness of neutrons
is very important to assess the dose in a real clinical case.
Conclusions
The absorbed depth dose distribution of the primary
neutrons and photons of the FRM II beam was calcu-
lated using GEANT4 in a voxelised water phantom, and
a very good agreement with measured data was found.
The voxel-algorithm of GEANT4 was validated and
influences of the surrounding walls on the dose in the
main beam were studied.
The voxel phantom REGINA [31] was used as a first
test and a 3D dose distribution of a salivary gland was
calculated. The depth dose curve obtained was com-
pared to that in the water phantom and the lateral dis-
t r i b u t i o ni nd i f f e r e n td e p t h sw a sd i s c u s s e di nd e t a i l .
Furthermore, the dose volume histogram of this test
case was calculated and the isodose representations in
o n es l i c eg i v e na sa ne x a m p l e .I ti se m p h a s i z e dt h a tt h e
calculations described in the present work were done
using a parallel neutron beam impinging on the human
voxel phantom. Any allowance for beam divergence is
expected to modify the calculated isodose lines and
DVHs somewhat. Thus, before any more realistic 3D
distributions can be given for an individual patient, the
beam characteristics and its influence on the 3D dose
distribution within a patient should be investigated in
detail. In this respect, the given dose distributions (see
Figures 7, 8, 9 and 10) should be interpreted still with
care. Nevertheless, it is noted that the given dose distri-
butions represent a major step forward in planning of
fast-neutron therapy at FRM II, as they are based on
quite realistic neutron and photon input spectra, and a
realistic human morphology. Note that, to the best of
our knowledge, GEANT4 has never been used for this
application, and so far only simple water phantoms are
being used in the certified dose estimate procedure
applied at the MEDAPP facility.
GEANT4 allows to assess a biological dose using radia-
tion weighting factors. Such factors can include particle
type, energy and energy loss as well as dose deposition or
other quantities like oxygen content or radiation sensitiv-
ity of the tissue involved. For the case of chromosomal
aberrations Schmid et al. [39] have shown that the irra-
diation is more effective in the first few centimeters of
tissue compared to deeper regions. Similar results were
obtained by Magaddino et al. [40] for the tumor control
probability and the RBE for permanent colony control.
The effect was qualitatively shown in this paper by apply-
ing a clinical RBE and could also be seen when artificial
RBEs were implemented in the Monte Carlo calculation
[33,41]. This helps to lessen the problem of high doses in
healthy organs on the patient’s side which is opposite to
the beam. In the future, cell experiments like [42-44] will
be used to improve the biological weighting of the dose.
It is concluded that the results presented here repre-
sent a significant step further towards a reliable, patient-
specific treatment planning system at the fast-neutron
therapy facility MEDAPP. However, further work needs
to be done including modeling of beam divergence and
exploring the influence of patient-specific parameters on
organ doses, before more accurate patient-specific organ
doses can be calculated. It is also planned in the future
to apply the present approach to physical humanoid
phantoms.
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